The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prevalence and prognostic significance of FGF receptor 2 (FGFR2) gene amplification in Caucasian and Korean gastric cancer cohorts.
Elaine Kilgour
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Xinying Su
Employment or Leadership Position - AstraZeneca
Ping Zhan
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Paul Gavine
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Shethah Morgan
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Chris Womack
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Eun-Jung Jung
No relevant relationships to disclose
Yung-Jue Bang
Consultant or Advisory Role - AstraZeneca
Honoraria - AstraZeneca
Research Funding - AstraZeneca
Seock-Ah Im
Research Funding - AstraZeneca
Woo Ho Kim
Research Funding - AstraZeneca; GlaxoSmithKline
Heike Grabsch
Consultant or Advisory Role - AstraZeneca
Honoraria - AstraZeneca
Research Funding - AstraZeneca